Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
4.320
+0.140 (3.35%)
At close: Apr 28, 2026, 4:00 PM EDT
4.370
+0.050 (1.16%)
After-hours: Apr 28, 2026, 6:42 PM EDT
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$163,652
Profits / Employee
-$167,543
Market Cap
36.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 123 |
| IGC Pharma | 70 |
| Senti Biosciences | 34 |
| Palatin Technologies | 29 |
| Boundless Bio | 28 |
| Outlook Therapeutics | 17 |
| CervoMed | 15 |
EVAX News
- 1 day ago - Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer - GlobeNewsWire
- 11 days ago - Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial - GlobeNewsWire
- 12 days ago - Evaxion concludes Annual General Meeting - GlobeNewsWire
- 4 weeks ago - Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress - GlobeNewsWire
- 5 weeks ago - Notice to convene Evaxion's Annual General Meeting - GlobeNewsWire
- 7 weeks ago - Evaxion announces business update and full year 2025 financial results - GlobeNewsWire
- 7 weeks ago - Evaxion plans to file 2025 annual report later today - GlobeNewsWire
- 2 months ago - Evaxion to announce business update and full year 2025 financial results on March 5, 2026 - GlobeNewsWire